7.1.1.2 Beta 3 adrenoceptor agonists

1st line option for patients in whom antimuscarinics are contraindicated and 2nd line for patients in whom antimuscarinics are ineffective or have unacceptable side effects. Please refer to    Primary Care Management of Over Active Bladder in women   Primary Care Management of Over Active Bladder in women  (here).